Cravath partner Susan Webster was featured in an article in The Deal entitled “No Way Out,” which discussed the sale by Bristol-Myers of its ConvaTec wound-therapeutics and ostomy unit to Nordic Capital and Avista Capital Partners. The $4.1 billion transaction was the largest leveraged buy-out announced to date during 2008 and was featured as one of the private equity deals of the year in the July 7, 2008, edition of The Deal.
Please click here to read the article.